Abstract
Governmental health agencies frequently issue warnings about new health hazards (e.g., smoking and excessive drinking). This chapter discusses factors affecting adherence to governmental warnings against the use of household products previously perceived safe. To be effective, a health warning must reach its intended audience and bring about behavior modification. This is challenging because, in order to modify behavior, the warning message must counteract and overpower the effect of habitual safe experience. Indeed the questions of how people perceive such warnings, whether they adhere to them, and what promotes or prevents adherence are central in marketing practice and research.
In this chapter, we review the psychological decision-making literature on trust of the source issuing the warning and safe experience with the risk-causing agent. Next we touch on basic requirements of awareness and understanding of the message. We then review the marketing literature on message design, focusing on factors practical for widespread implementation (i.e., vividness of message, one-sided vs. two-sided messages, regulatory fit). Next, based on behavioral decision research, we discuss how to counteract cognitive and emotional consumer biases that may reduce adherence. Finally, as a case in point, we evaluate adherence to the 2008 United States Food and Drug Administration (FDA) warning against administration of over-the-counter cough and cold medication (OTC-CCM) in children under age 2. We describe the results of three studies that examine whether parents had heard about OTC-CCM warnings and whether they intended to adhere to them. We conclude with recommendations for optimizing the design and dissemination of similar warnings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
For an exhaustive treatment of the topic, we refer the interested reader to the meta-analysis of 60 studies and 22,500 participants by Keller and Lehmann (2008), showing that message tactics have a significant impact upon intention to adhere to health-related recommendations.
References
Akhayan-Toysekani G, Chang YJ, Ahmed SR (United States Food and Drug Administration (FDA), Division of Drug Risk Evaluation) (2007) Postmarketing safety review of serious adverse events in children less than 6 years of age associated with the use of cough and cold medications. http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4323b1-02-FDA.pdf. Accessed 28 June 2011
Avis NE, Smith KW, Link CL, Goldman MB (2004) Increasing mammography screening among women over age 50 with a videotape intervention. Prev Med 39(3):498–506
Barnett J, Cooper H, Senior V (2007) Belief in public efficacy, trust, and attitude toward modern genetic science. Risk Anal 27(4):921–933
Barron G, Erev I (2003) Small feedback-based decisions and their limited correspondence to description-based decisions. J Behav Decis Mak 16(3):215–233
Barron G, Leider S, Stack J (2008) The effect of safe experience on a warnings’ impact: sex, drugs, and rock-n-roll. Organ Behav Hum Decis Process 106(2):125–142
Block LG, Keller PA (1997) Effects of self-efficacy and vividness on the persuasiveness of health communications. J Consum Psychol 6(1):31–54
Brown D (2008) Curbing cough syrup for kids: FDA weighs limits on use of remedies. The Washington Post (October 7), HE01. http://www.washingtonpost.com/wp-dyn/content/article/2008/10/03/AR2008100303245_pf.html. Accessed 28 June 2011
Brown PR (2009) The phenomenology of trust: a Schutzian analysis of the social construction of knowledge by gynaeoncology patients. Health Risk Soc 11(5):391–407
Brown P, Calnan M (2010) Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products. Health (London) 16(1):57–75
Carmon Z, Wertenbroch K, Zeelenberg M (2003) Option attachment: when deliberating makes choosing feel like losing. J Consum Res 30(1):15–29
Casiday RE (2007) Children’s health and the social theory of risk: insights from the British measles, mumps, and rubella (MMR) controversy. Soc Sci Med 65(5):1059–1070
Casiday R, Cresswell T, Wilson D, Panter-Brick C (2006) A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 24(2):177–184
Centers for Disease Control and Prevention (CDC) (2007) Infant deaths associated with cough and cold medications—two states, 2005. MMWR. Morbidity and Mortality Weekly Report 56(1):1–4. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5601a1.htm. Accessed 28 June 2011
Dijksterhuis A, Bos MW, Nordgren LF, van Baaren RB (2006) On making the right choice: the deliberation-without-attention effect. Science 311(5763):1005–1007
Epstein S (1994) Integration of the cognitive and the psychodynamic unconscious. Am Psychol 49(8):709–724
Erev I, Barron G (2005) On adaptation, maximization, and reinforcement learning cognitive strategies. Psychol Rev 112(4):912–931
Fox CR, Hadar L (2006) ‘Decisions from experience’ = sampling error + prospect theory: reconsidering Hertwig, Barron, Weber & Erev (2004). Judgm Decis Mak 1(2):159–161
Hanoch Y, Gummerum M, Miron-Shatz T, Himmelstein M (2010) Parents’ decision following the Food and Drug Administration recommendation: the case of over-the-counter cough and cold medication. Child Care Health Dev 36(6):795–804
Harris, Gardiner (2005) F.D.A. Official admits ‘lapses’ on Vioxx. The New York Times (March 5). http://www.nytimes.com/2005/03/02/politics/02fda.html. Accessed 28 June 2011
Hastings G, MacFadyen L (2002) The limitations of fear messages. Tob Control 11(11):73–75
Hertwig R, Barron G, Weber EU, Erev I (2004) Decisions from experience and the effect of rare events in risky choice. Psychol Sci 15(8):534–539
Himmelstein M, Miron-Shatz T, Hanoch Y, Gummerman M (2011) Over-the-counter cough and cold medicines for children: parental usage, perception and trust in governmental health organizations. Health Risk Soc 13:451–4685
Hobson-West P (2007) ‘Trusting blindly can be the biggest risk of all’: organized resistance to childhood vaccination in the UK. Sociol Health Illn 29(2):198–215
Jackson L, Putnam W, Twohig P, Burge F, Nicol K, Cox J (2004) What has trust got to do with it? Cardiac risk reduction and family physicians’ discussions of evidence-based recommendations. Health Risk Soc 6(3):239–255
Johnson EJ, Goldstein D (2003) Do defaults save lives? Science 302(5649):1338–1339
Kahneman D, Tversky A (1979) Prospect theory: an analysis of decision under risk. Econometrica 47(2):263–291
Kees J, Scot Burton J, Andrews C, Kozup J (2006) Tests of graphic visuals and cigarette package warning combinations: implications for the framework convention on tobacco control. J Publ Pol Market 25(2):212–223
Keller PA (2006) Regulatory focus and efficacy of health messages. J Consum Res 33(1):109–114
Keller PA, Block LG (1997) Vividness effects: a resource-matching perspective. J Consum Res 24(3):295–304
Keller PA, Lehmann DR (2008) Designing effective health communications: a meta-analysis. J Publ Pol Market 27(2):117–130
Laugesen MJ, Rice T (2002) Appendix: overview of the health service systems in ten developed countries. In: Rice T (ed) The economics of health reconsidered, 2nd edn. Health Administration Press, Chicago, pp 275–305
Lemal M, Van den Bulck J (2010) Testing the effectiveness of a skin cancer narrative in promoting positive health behavior: a pilot study. Prev Med 51(2):178–181
Li SYW, Rakow T, Newell BR (2009) Personal experience in doctor and patient decision making: from psychology to medicine. J Eval Clin Pract 15(6):993–995
Loewenstein GF, Weber EU, Hsee CK, Welch N (2001) Risk as feelings. Psychol Bull 127(2):267–286
Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, Choi L, Johnston PE, Rothman RL (2009) Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics 123(6):1464–1471
Mechanic D (2004) In my chosen doctor I trust: and that trust transfers from doctors to organizations. Br Med J 329(7480):1418–1419
Medicines and Healthcare Products Regulatory Agency (MHRA) (2008) Press release: updated advice—over-the-counter cough and cold medicines for young children. http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON014446. Accessed June 28, 2011
Medicines and Healthcare Products Regulatory Agency (MHRA) (2009) Press release: better medicines for children’s coughs and colds. http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON038902. Accessed 28 June 2011
Miron-Shatz T, Barron G, Hanoch Y, Gummerman M, Doniger GM (2010) To give or not to give: parental experience and adherence to the food and drug administration warning about over-the-counter cough and cold medicine usage. Judgm Decis Mak 5(6):428–436
Morgan MG, Fischhoff B, Bostrom A, Atman CJ (2002) Risk communication: a mental models approach. Cambridge University Press, New York
National Public Radio/Kaiser Family Foundation/Harvard School of Public Health (2007) Children’s OTC cold medicines: the public, and parents weigh in. http://www.kff.org/kaiserpolls/pomr121307pkg.cfm. Accessed 28 June 2011
O’Donoghue T, Rabin M (1999) Doing it now or later. Am Econ Rev 89(1):103–124
O’Neill O (2002) A question of trust: the BBC Reith lectures 2002. Cambridge University Press, Cambridge
Pechman C, Zhao G, Goldberg ME, Reibling ET (2003) What to convey in antismoking advertisements for adolescents: the use of protection motivation theory to identify effective message themes. J Market 67(2):1–18
Ratner RK, Soman D, Zauberman G, Ariely D, Carmon Z, Keller PA, Kyu Kim B, Lin F, Malkoc S, Small DA, Wertenbroch K (2008) How behavioral decision research can enhance consumer welfare: from freedom of choice to paternalistic intervention. Market Lett 19(3–4):383–397
Rucker DD, Petty RE, Brinol P (2008) What’s in a frame anyway?: A meta-cognitive analysis of the impact of one versus two-sided message framing on attitude certainty. J Consum Psychol 18(2):137–149
Schaefer MK, Shehab N, Cohen AL, Budnitz DS (2008) Adverse events from cough and cold medications in children. Pediatrics 121(4):783–787
Slovic P, Finucane M, Peters E, MacGregor DG (2002) The affect heuristic. In: Gilovich T, Griffin D, Kahnemann D (eds) Heuristics and biases: the psychology of intuitive judgment. Cambridge University Press, New York, pp 397–420
Slovic P, Finucane ML, Peters E, MacGregor DG (2004) Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal 24(2):311–322
Smith SM, Shaffer DR (2000) Vividness can undermine or enhance message processing: the moderating role of vividness congruency. Pers Soc Psychol Bull 26(7):769–779
Soman D (1998) The illusion of delayed incentives: evaluating future effort-money transactions. J Market Res 35(4):427–437
Taylor-Gooby P (2006) Trust, risk and health care reform. Health Risk Soc 8(2):97–103
Taylor-Gooby CH, Bromley C (2003) Querulous citizens: welfare knowledge and the limits to welfare reform. Soc Pol Admin 37(1):1–20
Thaler RH, Sunstein CR (2003) Behavioral economics, public policy, and paternalism: libertarian paternalism. Am Econ Rev 93(2):175–179
Thaler RH, Sunstein CR (2009) Nudge: improving decisions about health, wealth, and happiness. Penguin, London
United States Food and Drug Administration (FDA) (2008) FDA releases recommendations regarding use of over-the-counter cough and cold products: products should not be used in children under 2 years of age; evaluation continues in older populations. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116839.htm. Accessed 28 June 2011
United States Food and Drug Administration (FDA) (2010) About FDA: what we do http://www.fda.gov/aboutfda/whatwedo/default.htm. Accessed 28 June 2011
United States Food and Drug Administration (FDA) (2011a) MGA recalls item #504788 Bratz makeup design sketch book because of possible health risk. http://www.fda.gov/Safety/Recalls/ucm258088.htm. Accessed 28 June 2011
United States Food and Drug Administration (FDA) (2011b) Kashi recalls select frozen pizzas because they may contain plastic fragments. http://www.fda.gov/Safety/Recalls/ucm258012.htm. Accessed 28 June 2011
United States Food and Drug Administration (FDA) (2011c) FDA intends to remove unapproved drugs from market. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/ucm245228.pdf. Accessed 28 June 2011
Walls J, Pidgeon N, Weyman A, Horlick-Jones T (2004) Critical trust: understanding lay perceptions of health and safety risk regulation. Health Risk Soc 6(2):133–150
Williams DJ, Noyes JM (2007) How does our perception of risk influence decision-making? Implications for the design of risk information. Theor Issues Ergon Sci 8(1):1–35
Wilson TD, Schooler JW (1991) Thinking too much: introspection can reduce the quality of preference and decisions. J Pers Soc Psychol 60(2):181–192
World Health Organization (WHO) (2003) WHO framework convention on tobacco control http://whqlibdoc.who.int/publications/2003/9241591013.pdf. Accessed 28 June 2011
Zauberman G (2003) The intertemporal dynamics of consumer lock-in. J Consum Res 30(3):405–419
Zauberman G, Lynch JG Jr (2005) Resource slack and propensity to discount delayed investments of time versus money. J Exp Psychol Gen 134(1):23–37
Zhao G, Pechmann C (2007) The impact of regulatory focus on adolescents’ response to antismoking advertising campaigns. J Market Res 44(4):671–687
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Miron-Shatz, T., Doniger, G.M., Hanoch, Y. (2014). Factors Affecting Adherence to Governmental Health Warnings and the Case of Over-the-Counter Cough and Cold Medications (OTC-CCM) in Children Under Two. In: Ding, M., Eliashberg, J., Stremersch, S. (eds) Innovation and Marketing in the Pharmaceutical Industry. International Series in Quantitative Marketing, vol 20. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7801-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7801-0_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7800-3
Online ISBN: 978-1-4614-7801-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)